BDSIライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (23 3月 2022 @ 05:00):

Stats
本日の出来高	2.11M
平均出来高	3.35M
時価総額	577.05M
EPS	$0.650 ( Q4 \| 2022-03-09 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	6.82 (Sector) 42.63 (Industry) 30.78
ATR14	$0.0920 (1.65%)

AERI 0.00%

ALVO 1.33%

ALVOW 6.79%

BDSI -0.09%

BFRIW -5.93%

CLVRW 0.00%

CYTHW -4.35%

ENDP 0.00%

GRVI 7.61%

HPCO 0.06%

INDV -1.59%

JUPWW -20.00%

LFCR -0.19%

LNDC -3.52%

LSDI -23.29%

PRFX -3.65%

PROCW 10.09%

QLI 6.82%

SBFMW 0.00%

SHOT 9.43%

SHPH 4.28%

Insider Trading

Date	Person	Action	Amount	type
2022-03-22	Watson W. Mark	Sell	54 740	Stock Options (right to buy)
2022-03-22	Watson W. Mark	Sell	90 663	Common Stock
2022-03-22	Vollins James	Sell	91 401	Restricted Stock Units
2022-03-22	Vollins James	Sell	29 826	Stock Options (right to buy)
2022-03-22	Vollins James	Sell	43 334	Stock Options (right to buy)

INSIDER POWER
0.00
Last 100 transactions
Buy: 5 634 641 \| Sell: 24 333 206

ボリューム相関

長: 0.22 (neutral)

短: 0.00 (neutral)

Signal:(83.092) Neutral

BioDelivery Sciences 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

BioDelivery Sciences 相関 - 通貨/商品

-0.61
( weak negative )

0.51
( weak )

0.10
( neutral )

-0.44
( neutral )

-0.61
( weak negative )

0.44
( neutral )

BioDelivery Sciences 財務諸表

Annual	2021
収益:	$166.70M
総利益:	$143.33M (85.98 %)
EPS:	$0.850

FY	2021
収益:	$166.70M
総利益:	$143.33M (85.98 %)
EPS:	$0.850

FY	2020
収益:	$156.47M
総利益:	$131.81M (84.24 %)
EPS:	$0.260

FY	2019
収益:	$111.39M
総利益:	$89.80M (80.62 %)
EPS:	$-0.180

Financial Reports:

No articles found.

BioDelivery Sciences Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

BioDelivery Sciences

BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products for chronic conditions in the United States and internationally. The company provides its products based on its patented BioErodible MucoAdhesive drug-delivery technology, a small erodible polymer film for application to the buccal mucosa, as well as other drug delivery technologies. It offers BELBUCA, a buprenorphine buccal film for the treatment of chronic pain; and Symproic, a peripherally acting mu-opioid receptor antagonist for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent opioid dosage escalation. The company also provides ELYXYB, a celecoxib oral solution for the treatment of migraine with or without aura in adults; and ONSOLIS, a fentanyl buccal soluble film for the management of breakthrough pain in cancer patients. BioDelivery Sciences International, Inc. was incorporated in 1997 and is headquartered in Raleigh, North Carolina. As of March 18, 2022, BioDelivery Sciences International, Inc. operates as a subsidiary of Collegium Pharmaceutical, Inc.